Transrectal ultrasound–guided prostate biopsy

Changed by Daniel J Bell, 21 Oct 2020

Updates to Article Attributes

Title was changed:
ProstateTransrectal ultrasound–guided prostate biopsy
Body was changed:

Transrectal ultrasound–guided prostate biopsy is considered the standard approach for prostate biopsy and is most commonly performed on an outpatient with abasis following positive screening for prostate cancer It is not a targeted biopsy procedure. 

Nowadays, with the MRI capacity for depicting abnormal areas of the prostate, it is possible to obtainperform targeted sampling of prostate lesions with the use ofguided by real-time MR imaging–guided prostate biopsy.

Indications

Prostate cancer screening consists of PSA concentrationprostate specific antigen (PSA) measurement in the serum and a digital rectal examination. Positivity in one of these tests make patients candidates for further diagnostic evaluation with a transrectal ultrasonography–guided prostate biopsy.

Contraindications

The contraindications must be considered individually in each case. Overall, the most important contraindicationcontraindications are:

  • uncooperative patient
    • sedation with a hypnotic agent (eg(e.g. propofol or midazolam) couldmight be performed and monitoredrequired +/- monitoring by an anaesthetist.
  • uncorrectable bleeding diathesis (abnormal coagulation indices)

Procedure

Pre-procedurePreprocedure

Antibacterial prophylaxis areis recommended and may follow institutional protocols. The recommended antibiotics for transrectal prostate biopsies madepublished by american urology associationthe American Urology Association include: quinolones, 1st / 2nd / 3rd generation cephalosporins,aminoglycoside +, aminoglycoside and metronidazole or clindamycin, and aztreonam +metronidazoleand metronidazole or clindamycin. 

SomeIn some institutions standardized a small, an enema is performed before the procedure to clean out the bowels and clear the rectum of faeces. Evidence However evidence shows that there wasis no significant difference in rates of infectious complications between patients submitted or not tohaving/not having formal bowel preparationprep if they are on antibacterial prophylaxis4.

Laboratory parameters for a safe procedure

Many patients that underwentundergo prostate biopsy have increased cardiovascular risk and make continued use ofare on anticoagulants or antiplatelet therapymedication. The decision to suspend or maintain these therapies must be taken together with the patient's physician, taking into account the risks of bleeding and of a cardiovascular event.

In patients without disease or use of drugs that cause bleeding diathesisantibleeding agents, pre-procedure laboratory exams may not be necessary. Although, some institutional protocols andin some specific cases could demand for ainstitutions it is standard protocol to obtain blood testtests in all cases.

Complete blood count - Platelet: platelets > 50000;50000/mm23  (Some(some institutions determineuse other values between 50000-100000/mm3)2

Coagulation profile: Some studies showedshow that having a normal INR or prothrombin time is no reassuranceguarantee that the patient will not bleed after the procedure.

Positioning

Patient may be positionedplaced in the left lateral decubitus position with semi-flexedsemiflexed knees.

Biopsy
  1. Thethe lubricated ultrasound transducer is inserted into the patient’s rectum. Lidocaine gelA lidocaine preparation may be used as ultrsoundultrasound gel.
  2. Regionalregional block is administered around both neurovascular bundles (lidocaine).
  3. Biopsybiopsy needle is introduced. US–guided prostate biopsy is not a targeted biopsy procedure. The
  4. the prostate sampling technique is based on the sextant protocol, described by Hodge et al. and modified later, in which samples wereare obtained of the more peripheral zone (where the diagnostic yield is higher) from the base through the middle to the apex of the gland, bilaterally. Usually are 12 samples are taken, two per sextantesextant.
Post-procedure care

The recovery process will vary depending on the type of anesthesia that is used. In the usual technique, with only local anesthetic, the patient canmay resume yourtheir normal activities and diet. 

Patient should be instructedconsented about somepossible light bleeding from histhe rectum. That he may note blood in urine or stools, mild haematuria and/or haematochezia for a few days and that his semen may have a red or rust-colored tint caused by a small amount of blood.

It should be reemphasizedre-emphasized the continued use of antibiotic, as institutional protocols.

Complications

Minor complications are frequent, such as limited hematuria and hematospermia (may persist as long as 1 week after the biopsy). Reported infection rates are variable but low with the use of prophylactic antibiotics (Septicemia(septicemia requiring hospitalization occurred in less than 4% of patients1).

  • -<p>Transrectal ultrasound–guided biopsy is considered the standard approach for <strong>prostate biopsy</strong> and is most commonly performed on an outpatient with a positive screening for <a href="/articles/prostatic-carcinoma-1">prostate cancer</a>. </p><p>Nowadays, with the MRI capacity for depicting abnormal areas of the prostate, is possible to obtain targeted sampling of prostate lesions with the use of real-time MR imaging–guided prostate biopsy.</p><h4>Indications</h4><p>Prostate cancer screening consists of PSA concentration in serum and a digital rectal examination. Positivity in one of these tests make patients candidates for further diagnostic evaluation with a transrectal ultrasonography–guided prostate biopsy.</p><h4>Contraindications</h4><p>The contraindications must be considered individually in each case. Overall, the most important contraindication are:</p><ul>
  • -<li>uncooperative patient<ul><li>sedation with a hypnotic agent (eg. propofol or midazolam) could be performed and monitored by an anaesthetist.</li></ul>
  • +<p><strong>Transrectal ultrasound–guided prostate biopsy</strong> is considered the standard approach for prostate biopsy and is most commonly performed on an outpatient basis following positive screening for <a href="/articles/prostate-cancer-3">prostate cancer</a>.  It is not a targeted biopsy procedure. </p><p>Nowadays it is possible to perform targeted sampling of prostate lesions guided by real-time MR imaging.</p><h4>Indications</h4><p>Prostate cancer screening consists of <a href="/articles/prostate-specific-antigen-1">prostate specific antigen (PSA)</a> measurement in the serum and a <a href="/articles/digital-rectal-examination">digital rectal examination</a>. Positivity in one of these tests make patients candidates for further diagnostic evaluation with a transrectal ultrasonography–guided prostate biopsy.</p><h4>Contraindications</h4><p>The most important contraindications are:</p><ul>
  • +<li>uncooperative patient<ul><li>sedation with a hypnotic agent (e.g. propofol or midazolam) might be required +/- monitoring by an anaesthetist</li></ul>
  • -<li>uncorrectable bleeding diathesis (abnormal coagulation indices)</li>
  • -</ul><h4>Procedure</h4><h5>Pre-procedure</h5><p>Antibacterial prophylaxis are recommended and may follow institutional protocols. The recommended antibiotics for transrectal prostate biopsies made by american urology association include: quinolones, 1st / 2nd / 3rd generation cephalosporins,aminoglycoside + metronidazole or clindamycin, and aztreonam +metronidazole or clindamycin. </p><p>Some institutions standardized a small enema before the procedure to clean out bowels and clear the rectum of faeces. Evidence shows that there was no significant difference in rates of infectious complications between patients submitted or not to bowel preparation if they are on antibacterial prophylaxis<sup>4</sup>.</p><h6>Laboratory parameters for a safe procedure</h6><p>Many patients that underwent prostate biopsy have increased cardiovascular risk and make continued use of anticoagulants or antiplatelet therapy. The decision to suspend or maintain these therapies must be taken together with the patient's physician, taking into account the risks of bleeding and of a cardiovascular event.</p><p>In patients without disease or use of drugs that cause bleeding diathesis, pre-procedure laboratory exams may not be necessary. Although, some institutional protocols and some specific cases could demand for a blood test.  </p><p>Complete blood count - Platelet &gt; 50000/mm<sup>2</sup>  (Some institutions determine other values between 50000 -100000/mm<sup>3</sup>)<sup><a href="/articles/ct-guided-thoracic-biopsy">2</a></sup></p><p>Coagulation profile: Some studies showed that having a normal INR or prothrombin time is no reassurance that the patient will not bleed after the procedure.</p><ul>
  • -<li>international normalized ratio (INR) ≤ 1.5 <sup><a href="/articles/ct-guided-thoracic-biopsy">2</a></sup>
  • +<li>uncorrectable <a href="/articles/diathesis">bleeding diathesis</a> (abnormal coagulation indices)</li>
  • +</ul><h4>Procedure</h4><h5>Preprocedure</h5><p>Antibacterial prophylaxis is recommended and may follow institutional protocols. The recommended antibiotics for transrectal prostate biopsies published by the American Urology Association include: quinolones, 1st / 2nd / 3rd generation cephalosporins, aminoglycoside and metronidazole or clindamycin, and aztreonam and metronidazole or clindamycin. </p><p>In some institutions, an enema is performed before the procedure to clean out the bowels and clear the rectum of faeces. However evidence shows that there is no significant difference in rates of infectious complications between patients having/not having formal bowel prep if they are on antibacterial prophylaxis <sup>4</sup>.</p><h6>Laboratory parameters for a safe procedure</h6><p>Many patients that undergo prostate biopsy have increased cardiovascular risk and are on anticoagulants or antiplatelet medication. The decision to suspend or maintain these therapies must be taken together with the patient's physician, taking into account the risks of bleeding and of a cardiovascular event.</p><p>In patients without disease or use of antibleeding agents, pre-procedure laboratory exams may not be necessary. Although, in some institutions it is standard protocol to obtain blood tests in all cases.</p><p>Complete blood count: platelets &gt;50000/mm<sup><span style="font-size:10.8333px">3</span></sup> (some institutions use other values between 50000-100000/mm<sup>3</sup>) <sup>2</sup></p><p>Coagulation profile: studies show that having a normal INR or prothrombin time is no guarantee that the patient will not bleed after the procedure.</p><ul>
  • +<li>
  • +<a href="/articles/inr">international normalized ratio (INR)</a> ≤1.5 <sup>2</sup>
  • -<li>normal prothrombin time (PT), partial thromboplastin time (PTT)</li>
  • -</ul><h5>Positioning</h5><p>Patient may be positioned in the left lateral decubitus with semi-flexed knees.</p><h5>Biopsy</h5><ol>
  • -<li>The ultrasound transducer is inserted into the patient’s rectum. Lidocaine gel may be used as ultrsound gel.</li>
  • -<li>Regional block is administered around both neurovascular bundles (lidocaine).</li>
  • -<li>Biopsy needle is introduced. US–guided prostate biopsy is not a targeted biopsy procedure. The prostate sampling technique is based on the sextant protocol, described by Hodge et al. and modified later, in which samples were obtained of the more peripheral zone (where the diagnostic yield is higher) from the base through the middle to the apex of the gland, bilaterally. Usually are 12 samples, two per sextante. </li>
  • -</ol><h5>Post-procedure care</h5><p>The recovery process will vary depending on the type of anesthesia that is used. In the usual technique, with only local anesthetic, the patient can resume your normal activities and diet. </p><p>Patient should be instructed about some light bleeding from his rectum. That he may note blood in urine or stools for a few days and his semen may have a red or rust-colored tint caused by a small amount of blood.</p><p>It should be reemphasized the continued use of antibiotic, as institutional protocols.</p><h4>Complications</h4><p>Minor complications are frequent, such as limited hematuria and hematospermia (may persist as long as 1 week after the biopsy). Reported infection rates are variable but low with the use of prophylactic antibiotics (Septicemia requiring hospitalization occurred in less than 4% of patients<sup>1</sup>).</p>
  • +<li>normal <a href="/articles/prothrombin-time-pt">prothrombin time (PT)</a>, <a href="/articles/partial-thromboplastin-time-ptt">partial thromboplastin time (PTT)</a>
  • +</li>
  • +</ul><h5>Positioning</h5><p>Patient may be placed in the left lateral decubitus position with semiflexed knees.</p><h5>Biopsy</h5><ol>
  • +<li>the lubricated ultrasound transducer is inserted into the patient’s rectum. A lidocaine preparation may be used as ultrasound gel.</li>
  • +<li>regional block is administered around both neurovascular bundles (lidocaine).</li>
  • +<li>biopsy needle is introduced</li>
  • +<li>the prostate sampling technique is based on the sextant protocol, described by Hodge et al. and modified later, in which samples are obtained of the more peripheral zone (where the diagnostic yield is higher) from the base through the middle to the apex of the gland, bilaterally. Usually 12 samples are taken, two per sextant.</li>
  • +</ol><h5>Post-procedure care</h5><p>The recovery process will vary depending on the type of anesthesia that is used. In the usual technique, with only local anesthetic, the patient may resume their normal activities and diet. </p><p>Patient should be consented about possible light bleeding from the rectum, mild haematuria and/or haematochezia for a few days and that his semen may have a red or rust-colored tint caused by a small amount of blood.</p><p>It should be re-emphasized the continued use of antibiotic, as institutional protocols.</p><h4>Complications</h4><p>Minor complications are frequent, such as limited hematuria and hematospermia (may persist as long as 1 week after the biopsy). Reported infection rates are variable but low with the use of prophylactic antibiotics (septicemia requiring hospitalization occurred in less than 4% of patients <sup>1</sup>).</p>

Sections changed:

Updates to Link Attributes

Title was removed:
Prostate biopsy
Type was removed.
Visible was set to .

Updates to Link Attributes

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.